PubMed Health⌕ Search

Biomedical subjects

E Corse

Publications and source records attributed to E Corse.

3 recordsLinked to original sources

Analysis of secondary organic aerosol compounds from the photooxidation of d-limonene in the presence of NOx and their detection in ambient PM2.5.

Chemical analysis of secondary organic aerosol (SOA) from the photooxidation of a d-limonene/NOx/air mixture was carried out. SOA, generated in a smog chamber, was collected on Zefluor filters. To determine the structural characteristics of the compounds, the filter samples were solvent extracted and derivatized using analytical techniques that characterize functional groups contained in the compound: BF3-methanol derivatization was used for carboxylic groups, BSTFA for acidic and nonacidic hydroxyl groups, and PFBHA for ketone and aldehyde groups. The resulting derivative compounds were analyzed by GC-MS in the methane Cl and El modes. GC-MS analysis showed the occurrence of 103 oxygenated organic compounds in the filter extracts, 28 of which were identified. The major components include five tracer compounds previously identified from the photooxidation of alpha-pinene/NOx or beta-pinene/NOx systems, C4-C6 linear dicarboxylic acids, ketolimononaldehyde, limonic acid, and ketolimonic acid. Time profiles, yields, and proposed reaction schemes are provided for selected compounds. The laboratory SOA yield was 0.51 at a SOA concentration of 1470 microg m(-3). To determine the contributions of SOA products from d-limonene to ambient PM2.5, an analysis was performed for eight ambient PM2.5 samples collected in the southeastern United States in summer 2003. GC-MS analysis showed the occurrence of 21 d-limonene SOA compounds, indicating the impact of d-limonene on the regional aerosol burden. Based on our analysis, two compounds (nos. 55 and 69), not observed from the photooxidation of alpha-pinene or beta-pinene, are candidate tracers for d-limonene in atmospheric particulate matter.

Aerosols↗

Infectious bronchitis virus E protein is targeted to the Golgi complex and directs release of virus-like particles.

The coronavirus E protein is a poorly characterized small envelope protein present in low levels in virions. We are interested in the role of E in the intracellular targeting of infectious bronchitis virus (IBV) membrane proteins. We generated a cDNA clone of IBV E and antibodies to the E protein to study its cell biological properties in the absence of virus infection. We show that IBV E is an integral membrane protein when expressed in cells from cDNA. Epitope-specific antibodies revealed that the C terminus of IBV E is cytoplasmic and the N terminus is translocated. The short luminal N terminus of IBV E contains a consensus site for N-linked glycosylation, but the site is not used. When expressed using recombinant vaccinia virus, the IBV E protein is released from cells at low levels in sedimentable particles that have a density similar to that of coronavirus virions. The IBV M protein is incorporated into these particles when present. Indirect immunofluorescence microscopy showed that E is localized to the Golgi complex in cells transiently expressing IBV E. When coexpressed with IBV M, both from cDNA and in IBV infection, the two proteins are colocalized in Golgi membranes, near the coronavirus budding site. Thus, even though IBV E is present at low levels in virions, it is apparently expressed at high levels in infected cells near the site of virus assembly.

Animals↗